相关实验视频
Updated: Jun 28, 2025

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
3.2K
皮肤专利管道动脉关闭后的心脏呼吸系统不稳定:一个多中心队列研究
Adrianne R Bischoff1, Carl H Backes2, Brian Rivera2
1Division of Neonatology, Department of Pediatrics, University of Iowa, Iowa City, IA.
The Journal of pediatrics
|April 14, 2024
概括
在早产婴儿中,透气管专利动脉管 (PDA) 关闭可能导致心肺呼吸综合征,主要涉及高血压和氧化问题. 术后低血压和内使用是罕见的.
科学领域:
- 新生儿心脏病学 新生儿心脏病学
- 干预心脏病学 干预心脏病学
- 儿科重症监护 儿科重症监护
背景情况:
- 专利性动脉管 (PDA) 在早产婴儿中很常见,具有显著的心肺呼吸系统风险.
- 过导管关闭是手术管理的替代方案,但其术后影响需要评估.
- 了解临床结果对于优化这种脆弱人群的护理至关重要.
研究的目的:
- 评估在过导管专利通道动脉关闭 (PDA) 后的临床特征. 在早产婴儿中.
- 为了确定术后心肺呼吸系统并发症的发生率.
- 描述透气管后心肺呼吸综合征的特征.
主要方法:
- 多中心回顾性队列研究.
- 包括2公斤以下的早产婴儿接受皮肤PDA关闭 (2018年8月 - 2021年7月).
- 收集了手术前和手术后 (前24小时) 的心肺呼吸系统稳定性指数;主要结局是透气管后心肺呼吸综合征 (血液动力学不稳定和/或通风/氧化不足).
主要成果:
- 分析了197名早产婴儿 (平均体重为1090克).
- 术后心肺呼吸综合征的主要综合结局发生在46名患者 (23.3%) 中.
- 系统性高血压和氧化失败是导致综合结果的主要因素.
结论:
- 在早产婴儿中,透气管后心肺呼吸综合征主要与全身高血压和氧化衰竭有关.
- 低血压和需要新的内类药物/血管压缩剂的情况不常见.
- 这些发现凸显了在跨导管PDA关闭后需要监测的特定风险.
相关概念视频
Pneumothorax-I
202
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
202
Acute Respiratory Failure-II
218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Acute Respiratory Failure-I
204
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
204
Endotracheal Tube Extubation
639
Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
639

